SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$73.52
Tradestie Score
51
Market Cap
$994.20M
Analyst Upside
+29.5%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$70.71
|
$6.68B | - | 59 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$84.71
|
$6.64B | - | 55 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.15
|
$6.38B | - | 52 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$35.98
|
$6.03B | - | 66 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$52.08
|
$6.02B | - | 58 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$90.18
|
$5.95B | - | 50 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$233.49
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$40.11
|
$5.80B | 12.8 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$301.82
|
$5.20B | 40.1 | 56 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$46.93
|
$4.94B | - | 56 | Compare |
More SYRE Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry